The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy (NITRATE-CIN)
Effect of Inorganic Nitrate on Contrast-induced Nephropathy in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention for Acute Coronary Syndrome (ACS): A Randomised Single-centre, Double-blind Placebo-controlled Trial
Sponsor: Barts & The London NHS Trust
A PHASE2 clinical study on Acute Coronary Syndrome and Acute Kidney Injury, this trial is completed. The trial is conducted by Barts & The London NHS Trust and has accumulated 8 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Dec 2022 — Jan 2023 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Dec 2022 [monthly]
Recruiting PHASE2
▶ Show 3 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2019 — Dec 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Barts & The London NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .